Morgan Stanley
CRDL

Morgan Stanley’s Cardiol Therapeutics CRDL Stock Holding History

Morgan Stanley’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Buy
355,030
+104,609
+42% +$132K ﹤0.01% 5674
2026
Q1 		$338K Sell
250,421
-94,042
-27% -$96.5K ﹤0.01% 5660
2025
Q4 		$329K Buy
344,463
+188,132
+120% +$197K ﹤0.01% 5719
2025
Q3 		$167K Buy
156,331
+56,450
+57% +$68.5K ﹤0.01% 5955
2025
Q2 		$136K Buy
99,881
+40,268
+68% +$46.9K ﹤0.01% 6014
2025
Q1 		$57.8K Sell
59,613
-144,930
-71% -$178K ﹤0.01% 6222
2024
Q4 		$262K Buy
204,543
+140,843
+221% +$237K ﹤0.01% 5684
2024
Q3 		$126K Buy
63,700
+36,400
+133% +$75.5K ﹤0.01% 5907
2024
Q2 		$55.1K Buy
+27,300
New +$57.9K ﹤0.01% 6138
2023
Q4 		– Sell
-100
Closed -$90 – 7842
2023
Q3 		$90 Buy
+100
New +$96 ﹤0.01% 7452
2023
Q1 		– Sell
-4,482
Closed -$2.29K – 7734
2022
Q4 		$2.29K Sell
4,482
-13,985
-76% -$8.53K ﹤0.01% 7336
2022
Q3 		$19K Buy
18,467
+12,664
+218% +$15.4K ﹤0.01% 6817
2022
Q2 		$7K Buy
5,803
+1,303
+29% +$1.85K ﹤0.01% 7310
2022
Q1 		$7K Sell
4,500
-4,551
-50% -$7.51K ﹤0.01% 7495
2021
Q4 		$17K Sell
9,051
-18,039
-67% -$49.8K ﹤0.01% 7272
2021
Q3 		$112K Buy
+27,090
New +$98.2K ﹤0.01% 6303

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $3.2B AUM 23.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Morgan Stanley's CRDL Position: Q2 2026 in Review

Morgan Stanley increased its Cardiol Therapeutics (CRDL) stake by 42% in Q2 2026, buying an estimated $132K and bringing the position to 355,030 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #5674.

Morgan Stanley first reported a position in CRDL in Q3 2021 and has held it in 16 quarters since. 52 funds tracked by Wall St. Rank hold CRDL as of Q2 2026.

  • Morgan Stanley held 355,030 shares of Cardiol Therapeutics worth $376K as of Q2 2026.
  • Morgan Stanley bought 104,609 Cardiol Therapeutics shares in Q2 2026, an estimated $132K.
  • Cardiol Therapeutics made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5674 holding.
  • Morgan Stanley first reported a position in Cardiol Therapeutics in Q3 2021 and has held it in 16 quarters since.
  • 52 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.